ocular side effects of glp 1 As the use GLP-1 medications continues to rise, researchers are exploring their potential impact on eye health. While these drugs can help manage diabetes and promote weight loss, recent studies suggest GLP 1 Blindness Risk |

Some had hoped that its efficacy would more closely resemble that of existing injections on the market which can result in up to a 20% body weight loss while others noted the trial drop-out rate of 12% due to side effects or personal reasons

With a likely NDA filing in Q4 2026, retatrutide could reach US patients in early-to-mid 2028

Bramante, thanks for joining us here on Minnesota Now

As a triple receptor agonist developed by Eli Lilly, it demonstrates promising results in human use in the management of obesity and type 2 diabetes within clinical research settings

Like any pharmacologically active peptide-based therapy, it also comes with a side effect profile that patients and clinicians need to understand